diprivan 10mg/ml(1% ) ampoule
20ml ampoule x 5 -
diprivan 10mg/ml(1% )vial
50 ml vial -
diprivan 1 % infusion
beta healthcare international limited plot no. lr 209/6554, mogadishu road, industrial - propofol - infusion - each ampoule or vial contains 10 mg propofol per - other general anesthetics
diprivan 2 % infusion
beta healthcare international limited plot no. lr 209/6554, mogadishu road, industrial - propofol - infusion - each vial contains propofol 20 mg per ml. - other general anesthetics
diprivan 1% 20 ml
pharmacare limited - propofol - injectable solution - each ml contains:; propofol 10,0 mg
fresenius propoven 2%- propofol emulsion
fresenius kabi usa, llc - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) to permit the emergency use of the unapproved product, fresenius propoven 2% (propofol 20 mg/ml) emulsion 100 ml, to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit (icu) setting. caution: there is a risk of unintentional overdose with this unapproved product. fresenius propoven 2% emulsion contains the same active ingredient, propofol, as fda-approved diprivan injectable emulsion usp 10 mg/ml, but contains double the concentration. because of this difference in concentration between this unapproved product and the fda-approved product, there is a risk of unintentional overdose. fresenius propoven 2% emulsion 100ml is not an fda-approved drug in the united states. however, fda has issued an eua permitting the emergency use of fresenius propoven 2% emulsion during the covid-19 pandemic. the scope of the eua is limited as follows
fresenius propoven 2%- propofol emulsion
fresenius kabi austria gmbh - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - the u.s. food and drug administration (fda) has issued an emergency use authorization (eua) to permit the emergency use of the unapproved product, fresenius propoven 2% (propofol 20 mg/ml) emulsion 100 ml, to maintain sedation via continuous infusion in patients greater than 16 years old who require mechanical ventilation in an intensive care unit (icu) setting. caution: there is a risk of unintentional overdose with this unapproved product. fresenius propoven 2% emulsion contains the same active ingredient, propofol, as fda-approved diprivan injectable emulsion usp 10 mg/ml, but contains double the concentration. because of this difference in concentration between this unapproved product and the fda-approved product, there is a risk of unintentional overdose. fresenius propoven 2% emulsion 100ml is not an fda-approved drug in the united states. however, fda has issued an eua permitting the emergency use of fresenius propoven 2% emulsion during the covid-19 pandemic. the scope of the eua is limited as follows
propofol sandoz 20 mg/ml injektionsvätska/infusionsvätska, emulsion
propofol sandoz 10 mg/ml injektionsvätska/infusionsvätska, emulsion
anesthesia s/i-50 propofol isopropyl alcohol
rx pharma-pack, inc. - propofol (unii: yi7vu623sf) (propofol - unii:yi7vu623sf) - propofol 10 mg in 1 ml